The volume of the repurchased equity is equivalent to a stake of 0.0142% with the buyback costs adding up to 45,700 levs, Sopharma said in a statement to the Bulgarian Stock Exchange (BSE).
The company has so far repurchased a total of 3.2 million shares, equivalent to a 2.43% stake. It plans to offer the shares to the shareholders of companies it will take over in the future.
Sopharma was trading 1.58% higher at 2.44 levs in a volume of 622 shares by 1400 GMT on the BSE on Monday.
(1 euro=1.95583 Bulgarian levs)